6 results
S-1
EX-2.1
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
, including antitrust statutes relating to submission of offers, in any material respect.
3.21 Corporate Documents. The Company Certificate and bylaws
S-1
EX-10.4
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
and/or in a position to influence a purchasing decision of an Amgen Therapeutic Product.
Section 1.58 “HSR Act” means the Hart-Scott-Rodino Antitrust … under or relating to the HSR Act, and HSR Filing or any applicable foreign antitrust or competition-related legal requirement. AMGEN and RBNC shall
S-1
EX-2.2
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
or exclusion; (ii) been in violation of any federal or state Law, including antitrust statutes relating to submission of offers; or (iii) committed
S-1
EX-10.2
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
national, state, county, city or other political subdivision.
Section 1.55 “HSR Act” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976 … in connection with proceedings under or relating to the HSR Act, and HSR Filing or any applicable foreign antitrust or competition-related legal requirement
S-1
EX-10.3
rx58jq14jn3yveiyfnor
25 Aug 23
IPO registration
5:03pm
- Prev
- 1
- Next